Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News United Therapeutics Corp UTHR

United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended... see more

Recent & Breaking News (NDAQ:UTHR)

Lifshitz & Miller LLP Announces Investigation of EZCORP, Inc., Flowserve Corporation, Halliburton Company, NCI, Inc., Parkway, Inc., United Therapeutics Corporation and ViewRay, Inc.

PR Newswire August 2, 2017

Today's Research Report Coverage on Healthcare Stocks -- Perrigo, Immune Pharma, Tonix Pharma, and United Therapeutics

PR Newswire August 1, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of United Therapeutics Corporation and Encourages Investors with Losses to Contact the Firm

Business Wire July 31, 2017

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

Business Wire July 31, 2017

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of United Therapeutics Corporation

Business Wire July 28, 2017

UTHR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of United Therapeutics Corporation

Business Wire July 28, 2017

Harwood Feffer LLP Announces Investigation of United Therapeutics Corporation

PR Newswire July 28, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of United Therapeutics Corporation

Business Wire July 28, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of United Therapeutics Corporation -- UTHR

Business Wire July 28, 2017

UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations

Business Wire July 27, 2017

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of United Therapeutics Corporation and Encourages Investors with Losses to Contact the Firm

Business Wire July 27, 2017

UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm

PR Newswire July 27, 2017

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of United Therapeutics Corporation

Business Wire July 27, 2017

Bragar Eagel & Squire, P.C. Is Investigating United Therapeutics Corporation (UTHR) on Behalf of Stockholders and Encourages Investors to Contact the Firm

Business Wire July 27, 2017

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of United Therapeutics Corporation

Business Wire July 27, 2017

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against United Therapeutics Corporation - UTHR

Business Wire July 27, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of United Therapeutics Corporation Investors

Business Wire July 27, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of IntelliPharmaCeutics International Inc. (IPCI)

PR Newswire July 27, 2017

United Therapeutics Corporation Reports Second Quarter 2017 Financial Results

PR Newswire July 27, 2017

Earnings Scheduled For July 27, 2017

Benzinga.com  July 27, 2017